We are live on ! Find out more
BIOTU

Biotech Acquisition Company Unit
BIOTU

Delisted

BIOTU was delisted on the 2nd of February, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of BIOTU yet.

BIOTU Hedge Fund Activity: Q1 2023 in Review

0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Unit (BIOTU) for Q1 2023, worth a combined $0 — down 100% from $540K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BIOTU and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Millennium Management, exiting entirely with an estimated $401K sold.

  • 0 institutional investors held Biotech Acquisition Company Unit (BIOTU) as of Q1 2023, down from 5 in Q4 2022.
  • Funds reported $0 of Biotech Acquisition Company Unit stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Biotech Acquisition Company Unit positions in Q1 2023 and 5 closed out, a net change of -5 holders.
  • The largest Biotech Acquisition Company Unit seller in Q1 2023 was Millennium Management, an estimated $401K sold.

Based on aggregated 13F filings for Q1 2023.